GlassScriptPhysician profile
Seth A Bellister
NPI 1891043956
$4,940.14
in general payments reported to CMS, 2019-2025
15 companies · $3,253 in 2025
The $3,253 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $176 · 2021: $471 · 2022: $445 · 2023: $20.21 · 2025: $3,253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $530 · Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $530.00 |
| Food and Beverage | $242.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,176.88 | 2025 | |
| Portola Pharmaceuticals, LLC | $349.22 | 2019 | |
| Tela Bio, INC. | $311.74 | 2022 | |
| Kci USA, INC. | $253.46 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $252.28 | 2019-2020 | |
| Integra Lifesciences Corporation | $141.89 | 2021 | |
| Heron Therapeutics, INC. | $131.89 | 2021-2023 | Zynrelef |
| Silk Road Medical, INC. | $113.05 | 2022 | |
| Aroa Biosurgery Incorporated | $47.50 | 2025 | |
| Davol INC. | $35.79 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $35.65 | 2021-2022 | |
| Solventum Corporation | $28.27 | 2025 | V.A.C. Veraflo, Abthera, Prevena |
| Allergan, INC. | $24.38 | 2021 | |
| Acell, INC. | $22.84 | 2020 | |
| Bolder Surgical LLC | $15.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Bellister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.